Search

Author/Creator Russell, Kevin

1. 1048. Double-Blind, Randomized, Placebo-Controlled Phase 2b Multicenter Trial of V160, a Replication-Defective Human Cytomegalovirus (CMV) Vaccine. (4th December 2021)

Authors:
Das, Rituparna; Blazquez-Gamero, Daniel; Bernstein, David I; Gantt, Soren; Bautista, Oliver; Beck, Karen; Conlon, Anthony; Rosenbloom, Daniel; Wang, Dai; Ritter, Michael; Arnold, Beth; Annunziato, Paula; Russell, Kevin
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S615
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1048. Double-Blind, Randomized, Placebo-Controlled Phase 2b Multicenter Trial of V160, a Replication-Defective Human Cytomegalovirus (CMV) Vaccine. (4th December 2021)

Authors:
Das, Rituparna; Blazquez-Gamero, Daniel; Bernstein, David I; Gantt, Soren; Bautista, Oliver; Beck, Karen; Conlon, Anthony; Rosenbloom, Daniel; Wang, Dai; Ritter, Michael; Arnold, Beth; Annunziato, Paula; Russell, Kevin
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S615
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 636. A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Quadrivalent Dengue Vaccine (V181). (4th December 2021)

Authors:
Russell, Kevin; Rupp, Richard E; Morales-Ramirez, Javier O; Diaz-Perez, Clemente; Andrews, Charles P; Lee, Andrew W; Finn, Tyler S; Cox, Kara; Russell, Amy Falk; Schaller, Margaret M; Martin, Jason C; Hyatt, Donna M; Gozlan-Kelner, Sabrina; Bili, Androniki; Coller, Beth-Ann
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗